Published in J Immunol on June 01, 2009
Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature (2013) 1.56
The νSaα Specific Lipoprotein Like Cluster (lpl) of S. aureus USA300 Contributes to Immune Stimulation and Invasion in Human Cells. PLoS Pathog (2015) 1.45
Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9. J Immunol (2012) 1.16
Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes. PLoS One (2010) 1.14
Human serum mannose-binding lectin senses wall teichoic acid Glycopolymer of Staphylococcus aureus, which is restricted in infancy. J Biol Chem (2010) 0.98
Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells. J Invest Dermatol (2013) 0.95
The Staphylococcus aureus lipoprotein SitC colocalizes with Toll-like receptor 2 (TLR2) in murine keratinocytes and elicits intracellular TLR2 accumulation. Infect Immun (2010) 0.94
Comparative genomics reveals distinct host-interacting traits of three major human-associated propionibacteria. BMC Genomics (2013) 0.93
The function of TLR2 during staphylococcal diseases. Front Cell Infect Microbiol (2013) 0.92
TRAM is required for TLR2 endosomal signaling to type I IFN induction. J Immunol (2014) 0.91
Auxiliary role for D-alanylated wall teichoic acid in Toll-like receptor 2-mediated survival of Staphylococcus aureus in macrophages. Immunology (2009) 0.83
Effects of deletion of the Streptococcus pneumoniae lipoprotein diacylglyceryl transferase gene lgt on ABC transporter function and on growth in vivo. PLoS One (2012) 0.82
NOD2 stimulation by Staphylococcus aureus-derived peptidoglycan is boosted by Toll-like receptor 2 costimulation with lipoproteins in dendritic cells. Infect Immun (2014) 0.82
Heterogeneity of host TLR2 stimulation by Staphylocoocus aureus isolates. PLoS One (2014) 0.81
The iron-regulated staphylococcal lipoproteins. Front Cell Infect Microbiol (2012) 0.81
Protective or deleterious role of scavenger receptors SR-A and CD36 on host resistance to Staphylococcus aureus depends on the site of infection. PLoS One (2014) 0.81
Skin-Specific Unsaturated Fatty Acids Boost the Staphylococcus aureus Innate Immune Response. Infect Immun (2015) 0.78
Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactants. Nat Commun (2016) 0.77
Evaluation of Staphylococcus aureus Lipoproteins: Role in Nutritional Acquisition and Pathogenicity. Front Microbiol (2016) 0.77
Staphylococcus aureus lipoteichoic acid inhibits platelet activation and thrombus formation via the Paf receptor. J Infect Dis (2013) 0.77
Lipoproteins of Gram-Positive Bacteria: Key Players in the Immune Response and Virulence. Microbiol Mol Biol Rev (2016) 0.77
Adaptive immune response to lipoproteins of Staphylococcus aureus in healthy subjects. Proteomics (2016) 0.76
T(H)17-Mediated Protection against Pneumococcal Carriage by a Whole-Cell Vaccine Is Dependent on Toll-Like Receptor 2 and Surface Lipoproteins. Clin Vaccine Immunol (2015) 0.76
Staphylococcus aureus Lpl Lipoproteins Delay G2/M Phase Transition in HeLa Cells. Front Cell Infect Microbiol (2016) 0.75
Toll-like receptor 9 enhances bacterial clearance and limits lung consolidation in murine pneumonia caused by methicillin resistant Staphylococcus aureus. Mol Med (2016) 0.75
Using Biotechnology to Solve Engineering Problems: Non-Destructive Testing of Microfabrication Components. Materials (Basel) (2017) 0.75
Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol (2005) 2.76
Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol (2005) 2.61
Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe (2010) 2.49
Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol (2006) 2.40
Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates. Infect Immun (2010) 2.33
Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infect Dis (2002) 2.16
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2007) 2.14
Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect Immun (2006) 2.13
Activity of the major staphylococcal autolysin Atl. FEMS Microbiol Lett (2006) 2.06
Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J Infect Dis (2002) 2.05
Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J Biol Chem (2005) 2.00
De Novo Arteriovenous Malformation Growth Secondary to Implantation of Genetically Modified Allogeneic Mesenchymal Stem Cells in the Brain. Neurosurgery (2016) 1.96
Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice. J Neurosci (2005) 1.94
Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog (2007) 1.92
Bacterial infections promote T cell recognition of self-glycolipids. Immunity (2005) 1.92
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc Natl Acad Sci U S A (2006) 1.92
Role of staphylococcal wall teichoic acid in targeting the major autolysin Atl. Mol Microbiol (2010) 1.82
Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection. Infect Immun (2005) 1.80
Comparative proteome analysis of Staphylococcus aureus biofilm and planktonic cells and correlation with transcriptome profiling. Proteomics (2006) 1.79
Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model. Infect Immun (2005) 1.78
Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect Immun (2005) 1.76
Bacteria-derived peptidoglycans constitute pathogen-associated molecular patterns triggering innate immunity in Arabidopsis. J Biol Chem (2007) 1.68
Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer? Microbiology (2005) 1.68
Arabidopsis lysin-motif proteins LYM1 LYM3 CERK1 mediate bacterial peptidoglycan sensing and immunity to bacterial infection. Proc Natl Acad Sci U S A (2011) 1.65
Identification of a 5-nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNA-binding properties of IcaR. Mol Microbiol (2003) 1.61
Bacterial evasion of innate host defenses--the Staphylococcus aureus lesson. Int J Med Microbiol (2004) 1.57
Inhibition of staphylococcal biofilm formation by nitrite. J Bacteriol (2007) 1.51
The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses. BMC Microbiol (2008) 1.51
Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J Bacteriol (2006) 1.50
Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J Neurosci (2006) 1.49
Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J Infect Dis (2003) 1.44
Solitary spinal artery aneurysms as a rare source of spinal subarachnoid hemorrhage: potential etiology and treatment strategy. AJNR Am J Neuroradiol (2005) 1.43
The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity. Infect Immun (2006) 1.41
YfiBNR mediates cyclic di-GMP dependent small colony variant formation and persistence in Pseudomonas aeruginosa. PLoS Pathog (2010) 1.40
Genome analysis of the meat starter culture bacterium Staphylococcus carnosus TM300. Appl Environ Microbiol (2008) 1.38
A Staphylococcus aureus ypfP mutant with strongly reduced lipoteichoic acid (LTA) content: LTA governs bacterial surface properties and autolysin activity. Mol Microbiol (2007) 1.34
Microevolution of cytochrome bd oxidase in Staphylococci and its implication in resistance to respiratory toxins released by Pseudomonas. J Bacteriol (2006) 1.33
Transcription of clumping factor A in attached and unattached Staphylococcus aureus in vitro and during device-related infection. Infect Immun (2002) 1.32
Suicidal erythrocyte death in sepsis. J Mol Med (Berl) (2006) 1.30
Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization. Int J Med Microbiol (2008) 1.29
Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. J Infect Dis (2008) 1.28
Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol (2010) 1.26
Capnocytophaga canimorsus: a human pathogen feeding at the surface of epithelial cells and phagocytes. PLoS Pathog (2008) 1.22
Silver coordination polymers for prevention of implant infection: thiol interaction, impact on respiratory chain enzymes, and hydroxyl radical induction. Antimicrob Agents Chemother (2010) 1.22
Lack of biofilm contribution to bacterial colonisation in an experimental model of foreign body infection by Staphylococcus aureus and Staphylococcus epidermidis. FEMS Immunol Med Microbiol (2003) 1.21
High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J Leukoc Biol (2002) 1.20
Structural basis of cell wall cleavage by a staphylococcal autolysin. PLoS Pathog (2010) 1.20
Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals. FASEB J (2010) 1.19
Marker removal in staphylococci via Cre recombinase and different lox sites. Appl Environ Microbiol (2007) 1.18
The ability of biofilm formation does not influence virulence of Staphylococcus aureus and host response in a mouse tissue cage infection model. Microb Pathog (2004) 1.18
Small-colony variant selection as a survival strategy for Staphylococcus aureus in the presence of Pseudomonas aeruginosa. Appl Environ Microbiol (2009) 1.16
Characterization of toxin production of coagulase-negative staphylococci isolated from food and starter cultures. Int J Food Microbiol (2008) 1.15
In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations. Nanotoxicology (2011) 1.15
Neutrophil chemotaxis by pathogen-associated molecular patterns--formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus. Cell Microbiol (2006) 1.14
Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes. PLoS One (2010) 1.14
Toll-like receptor 2 deficiency delays pneumococcal phagocytosis and impairs oxidative killing by granulocytes. Infect Immun (2005) 1.13
Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains. J Bacteriol (2009) 1.13
Phage release from biofilm and planktonic Staphylococcus aureus cells. FEMS Microbiol Lett (2005) 1.11
A novel staphylococcal internalization mechanism involves the major autolysin Atl and heat shock cognate protein Hsc70 as host cell receptor. Cell Microbiol (2010) 1.11
Advantage of upregulation of succinate dehydrogenase in Staphylococcus aureus biofilms. J Bacteriol (2010) 1.10
Reversible daptomycin tolerance of adherent staphylococci in an implant infection model. Antimicrob Agents Chemother (2011) 1.10
Neutrophil antimicrobial defense against Staphylococcus aureus is mediated by phagolysosomal but not extracellular trap-associated cathelicidin. J Leukoc Biol (2009) 1.08
Furanone at subinhibitory concentrations enhances staphylococcal biofilm formation by luxS repression. Antimicrob Agents Chemother (2009) 1.06
Staphylococcal major autolysin (Atl) is involved in excretion of cytoplasmic proteins. J Biol Chem (2010) 1.06
Characterization of the oxygen-responsive NreABC regulon of Staphylococcus aureus. J Bacteriol (2008) 1.05
T and B cells are not required for clearing Staphylococcus aureus in systemic infection despite a strong TLR2-MyD88-dependent T cell activation. J Immunol (2010) 1.04
Role of the twin-arginine translocation pathway in Staphylococcus. J Bacteriol (2009) 1.04
Ligand-binding properties and conformational dynamics of autolysin repeat domains in staphylococcal cell wall recognition. J Bacteriol (2012) 1.03
Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection. Antimicrob Agents Chemother (2007) 1.02
Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: mediation by interleukin-6 from Kupffer cells. Gastroenterology (2002) 1.01
Proton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activity. PLoS One (2012) 1.01
Intracellular type III secretion by cytoplasmic Shigella flexneri promotes caspase-1-dependent macrophage cell death. Microbiology (2007) 1.00
Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR gamma delta cells. Eur J Immunol (2008) 1.00
Pyruvate formate lyase acts as a formate supplier for metabolic processes during anaerobiosis in Staphylococcus aureus. J Bacteriol (2010) 0.98
CcpA coordinates central metabolism and biofilm formation in Staphylococcus epidermidis. Microbiology (2011) 0.97
Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother (2012) 0.96
Staphylococcal NreB: an O(2)-sensing histidine protein kinase with an O(2)-labile iron-sulphur cluster of the FNR type. Mol Microbiol (2004) 0.96
CD14 works with toll-like receptor 2 to contribute to recognition and control of Listeria monocytogenes infection. J Infect Dis (2008) 0.96
Innate immune recognition of microbial cell wall components and microbial strategies to evade such recognitions. Microbiol Res (2013) 0.95
CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection. J Leukoc Biol (2005) 0.94
Oligomeric coiled-coil adhesin YadA is a double-edged sword. PLoS One (2010) 0.94
Generation and functional characterization of a clonal murine periportal Kupffer cell line from H-2Kb -tsA58 mice. J Leukoc Biol (2003) 0.94
What distinguishes highly pathogenic staphylococci from medium- and non-pathogenic? Curr Top Microbiol Immunol (2013) 0.94
The two-component signal transduction system ArlRS regulates Staphylococcus epidermidis biofilm formation in an ica-dependent manner. PLoS One (2012) 0.93
Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm (2010) 0.93
Human chitotriosidase is expressed in the eye and lacrimal gland and has an antimicrobial spectrum different from lysozyme. Microbes Infect (2007) 0.92
Characterization and comparison of 2 distinct epidemic community-associated methicillin-resistant Staphylococcus aureus clones of ST59 lineage. PLoS One (2013) 0.92
Artifacts caused by cochlear implants with non-removable magnets in 3T MRI: phantom and cadaveric studies. Eur Arch Otorhinolaryngol (2009) 0.91
Transcriptomic and metabolic responses of Staphylococcus aureus exposed to supra-physiological temperatures. BMC Microbiol (2009) 0.91
Nonribosomal synthesis of fengycin on an enzyme complex formed by fengycin synthetases. J Biol Chem (2006) 0.91
The phage lytic proteins from the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistance. PLoS One (2013) 0.90